Network meta-analysis of 105 RCTs (219,283 participants): GLP-1 receptor agonists and SGLT2 inhibitors were not significantly associated with sepsis, abscess, gangrene or other infections vs control, except high-dose canagliflozin (300 mg/day), linked to lower sepsis risk.
Meta-analysisn = 219,283
Zeng et al. The effect of GLP-1 receptor agonist and SGLT2 inhibitor on infection risk: network meta-analysis